Antibacterial activity and pharmacokinetic behavior of cefazolin as compared with five other cephalosporin antibiotics.
D001419:Bacteria / Q000187:drug effects*; D002506:Cephalexin / Q000378:metabolism / Q000494:pharmacology; D002509:Cephaloridine / Q000378:metabolism / Q000494:pharmacology; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004754:Enterobacter / Q000187:drug effects; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007201:Indicator Dilution Techniques; D007273:Injections, Intramuscular; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008333:Mandelic Acids / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010146:Pain; D011485:Protein Binding; D011511:Proteus / Q000187:drug effects; D011513:Proteus mirabilis / Q000187:drug effects; D011514:Proteus vulgaris / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology; D013777:Tetrazoles / Q000494:pharmacology; D013830:Thiadiazoles / Q000494:pharmacology; D013997:Time Factors
D002511:Cephalosporins; D008333:Mandelic Acids; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D002509:Cephaloridine; D002506:Cephalexin